Most Popular Entries
Welcome to my editorial column!
The purpose of this column is to provide perspective on the issues that the biopharma industry we represent is addressing in collaboration with partners here in Geneva and around the world. These include the innovation ecosystem, vaccines, pandemic preparedness, antimicrobial resistance, access to medicines and many others. Over the years, I’ve written for a number of publications including a weekly column in the Basler Zeitung, a leading Swiss newspaper from my home town. Today, I am also a contributor to publications such as the New York Times, Project Syndicate, the Financial Times, the Diplomatic Courrier and Health Policy Watch. I have also been on a number of podcasts, reflecting my desire to understand the other side. I hope you enjoy my thoughts, which reflect my commitment to continue bringing you expertise and reflections on key issues and policies that relate to my work with IFPMA. I’m a regular commentator on COVID-19 issues. I know that in this fast-changing world, divergent opinions matter and I would like to engage you in these conversations and hear your thoughts as well. Please add your comments below or follow me on Twitter: @ThomasCueni or on LinkedIn.
So let’s get talking!
So let’s go digital and enjoy the journey!
Latest Global Health Matters
25 November, 2021
15 November, 2021
Latest Science Matters
15 November, 2016
02 October, 2015
12 March, 2015
About Our Blogs
IFPMA blogs are intended to further stimulate exchange and dialog on innovation and global health topics that matter to all of us.
Global Health Matters is a column on global health– we’re discussing topics ranging from sustainable health policies and the value of innovation through access to medicines, to the role of global health partnerships and challenges related to counterfeit medicines and more.
Science Matters is a column featuring new directions in innovation and current areas of research in medicine, penned by scientists working every day behind the scene to bring new solutions to the most challenging health needs.
Just as our bloggers have a point of view, we hope to know yours as we believe the only way we can make progress happen, is by collaborating, sharing, and coordinating information and ideas. Our promise to you is providing “food for thought? and your contribution can make it into a lively global health platform that will serve as a valuable resource for all
About the Editor
Our Communications Team works with the IFPMA team of experts, as well as experts from inside and outside the research-based biopharmaceutical industry, to produce interesting and thought-provoking blogs for our audience. We welcome blog posts from stakeholders, bloggers, and reporters interested in global health and innovation discussions. Should you wish to contribute a post, please review our blog submission guidelines.